Papers
12
Total Citations
237
H-Index
8
About
Sarah Drouin is a leading urologic oncologist whose research has fundamentally advanced the surgical management of localized prostate and bladder cancers. Her seminal 2009 study, comparing open, laparoscopic, and robot-assisted radical prostatectomy (RALP), remains a cornerstone in the field with 82 citations, providing critical evidence for the oncologic safety of minimally invasive approaches. Drouin’s work has consistently refined patient selection and prognostic accuracy, notably demonstrating that low free and bioavailable testosterone levels serve as predictors of high-grade tumors (38 citations), and clarifying the influence of pathological factors on RALP outcomes. She has also pioneered the application of robotic surgery in complex populations, including kidney transplant recipients, and has explored the role of image-guided radiosurgery (CyberKnife) for prostate cancer. Her prospective studies and narrative reviews on functional outcomes after robotic cystectomy with intracorporeal neobladder have shaped modern reconstructive techniques. With a career dedicated to correlating perioperative factors with long-term oncologic control, Drouin’s work has directly influenced clinical guidelines and improved surgical decision-making for thousands of patients worldwide.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10